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Abstract The effect of contrast medium SonoVue  on
the electric charge density of blood cells (erythrocytes and
thrombocytes) was measured using a microelectrophoretic
method. We examined the effect of adsorbed H
? and OH
-
ions on the surface charge of erythrocytes or thrombocytes.
Surface charge density values were determined from
electrophoretic mobility measurements of blood cells per-
formed at various pH levels. The interaction between
solution ions and the erythrocyte’s or thrombocyte’s sur-
face was described by a four-component equilibrium
model. The agreement between the experimental and the-
oretical charge variation curves of the erythrocytes and
thrombocytes was good at pH 2–9. The deviation observed
at a higher pH may be caused by disregarding interactions
between the functional groups of blood cells.
Keywords SonoVue   Erythrocyte   Thrombocyte  
pH measurement   Surface charge density   Association
constant
Introduction
Hepatic hemangiomas (congenital vascular malformations)
are the most common benign tumors, accounting for
9.4–22.7% of all diagnosed hepatic tumors (Numata et al.
2006; Tranquart et al. 2009; Tani et al. 2010; von Herbay
et al. 2010). Most of them are asymptomatic and require
no treatment; therefore, differentiation between hepatic
hemangiomas and hepatic malignant lesions is a frequent
challenge. Radiologists can use numerous methods to
diagnose hepatic tumors. Ultrasound is considered to be
inferior in comparison to computed tomography (CT), and
magnetic resonance imaging (MRI) using contrast agents
allows for an evaluation of its nature (Soyer et al. 1998;
Herman et al. 2005; Dietrich et al. 2007; Zviniene et al.
2010). The introduction of contrast medium for diagnosis
of various medical conditions has been associated with a
number of adverse effects such as nephropathy, thrombosis
and nephrogenic systemic ﬁbrosis (Carr et al. 1995;
Broome 2008; Feldkamp and Kribben 2008; Van Linden
et al. 2011). Currently, a growing number of centers per-
form contrast-enhanced ultrasonography (CEUS) with the
contrast agent SonoVue
 . Although the use of SonoVue is
characterized by a small amount of contraindications,
compared to other contrast media it has a good safety
proﬁle in abdominal applications, myocardial perfusion
assessment and transcranial ultrasound diagnostic (Kaps
et al. 1999; Bokor et al. 2001; Piscaglia and Bolondi 2006;
Dijkmans et al. 2009; Gaibazzi et al. 2009; Beaton et al.
2010). CEUS achieves comparable sensitivity and speci-
ﬁcity to CT and MRI (Bartolotta et al. 2007; Dietrich et al.
2007; Li et al. 2007; Tranquart et al. 2009; Beaton et al.
2010; von Herbay et al. 2010). We have used this method
since 2006, especially in people in whom CT or MRI is
contraindicated. No complications have been observed.
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SonoVue is for diagnostic use only. It is a contrast agent
(it helps make internal body structures visible during
imaging tests). SonoVue is used in tests that measure how
ultrasound travels within the body because it improves the
ability of the blood to create an echo. It is only used when
the results of the test without a contrast agent are
inconclusive.
SonoVue is used in the following:
• Echocardiography (a diagnostic test where an image of
the heart is obtained), to obtain a clearer scan of the
chambers of the heart, especially of the left ventricle, in
patients with suspected or conﬁrmed coronary artery
disease.
• Doppler (a diagnostic test that measures the speed of
blood ﬂow), in tests for large blood vessels, such as
those in the head and those leading to the head or the
main vein to the liver, or for smaller blood vessels, such
as those in lesions (areas of disease) in the breast or
liver.
A microscopic picture SonoVue microbubbles and a
schematic representation of the SonoVue microbubble
structure are presented in Fig. 1.
The total amount of sulfur hexaﬂuoride (SF6) adminis-
tered in a clinical dose is extremely small (in a 2-ml dose
the microbubbles contain 16 ll of gas). SF6 is an inert,
innocuous gas, poorly soluble in aqueous solutions. It
dissolves in the blood and is subsequently exhaled. More
than 80% of the administered SF6 was recovered in exhaled
air within 2 min after injection and almost 100% after
15 min (Schneider et al. 1995; Schneider 1999a, 1999b;
Greis 2004). SonoVue is a contrast agent of the second
generation that contains phospholipid-stabilized micro-
bubbles ﬁlled with SF6 with a diameter\8 lm (mean
2.5 lm). The physicochemical parameters of SonoVue are
presented in Table 1.
Biological membranes are characterized by a markedly
ordered structure and can be considered to be a distinct
phase from the physical point of view, separated from
surrounding cytoplasm or intermolecular biological ﬂuid.
Thus, the membrane surface can be approximated to an
interface. The membrane–medium interface is the site
where some physicochemical processes occur which are
characteristic of a typical interface, e.g., asymmetric dis-
tribution of electric charge (Nalecz and Wojtczak 1982).
Examining the electrical charge could reveal substantial
information about the balance between membrane com-
ponents but also between membrane components and the
surrounding solution. The electrical charge is determined
by structural positive charge carriers (free amino groups of
proteins and aminophospholipids) and by negative charge
carriers (some phospholipids, especially phosphatidylser-
ine, sialic acid, glycophorins and free carboxy groups of
polypeptide chains) (Szachowicz-Petelska et al. 2010).
The effect of contrast medium SonoVue on the electric
charge density of blood cells (erythrocytes and thrombo-
cytes) was measured using a microelectrophoretic method.
We describe the changes of electric charge density of the
Fig. 1 Microscopic picture and
schematic representation of
SonoVue microbubble structure
(Schneider et al. 1995;
Schneider 1999a, 1999b; Greis
2004)
Table 1 SonoVue physicochemical parameters
Concentration 1–5 9 10
8 ml
-1
Mean microbubble diameter 2.5 (lm)
SF6 encapsulated volume 8 (ll/ml)
SF6 volume in a 2.4-ml dose 0.02 (ml)
Osmolarity 290 (mOs/kg)
Viscosity 2 (mPa s)
pH 6.0–6.5
Stability after reconstitution 6 (h)
Data from Schneider et al. 1995; Schneider 1999a, 1999b
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over the pH range 2–11.
Theory
The dependence of the surface charge density of erythro-
cytes or thrombocytes as a result of SonoVue on the pH of
the electrolyte solution can be described using four equi-
librium equations. Two are connected with positive groups
(e.g., phospholipids or proteins and sodium and hydrogen
ions), and two concern the negative species of phospho-
lipids or proteins and hydroxide and chloride ions. The H
?,
OH
-,N a
? and Cl
- ions are adsorbed at the cell mem-
branes (erythrocytes or thrombocytes), and the adsorption
equilibria can be presented in the following form
(Dobrzynska et al. 2006, 2007):
A  þ Hþ , AH ð1Þ
A  þ Naþ , ANa ð2Þ
Bþ þ OH  , BOH ð3Þ
Bþ þ Cl  , BCl ð4Þ
Therefore, the association constants of the H
?,N a
?,O H
-
and Cl
- ions with functional groups are expressed in the
following manner (Dobrzynska et al. 2006, 2007):
KAH ¼
aAH
aA    aHþ
ð5Þ
KANa ¼
aANa
aA    aNaþ
ð6Þ
KBOH ¼
aBOH
aBþ   aOH  ð7Þ
KBCl ¼
aBCl
aBþ   aCl  ð8Þ
where KAH, KANa, KBOH andKBCl are association constants;
aAH, aANa, aA , aBOH, aBCl and aBþ are surface
concentrations of corresponding groups on the membrane
surface; and aHþ, aNaþ, aOH  and aCl are volume
concentrations of solution ions. The concentration
balances are expressed as follows (Dobrzynska et al. 2006):
CA ¼ aA  þ aAH þ aANa ð9Þ
CB ¼ aBþ þ aBOH þ aBCl ð10Þ
where CA is the total surface concentration of the mem-
brane acidic groups and CB is the total surface concentra-
tion of the membrane basic groups.
Surface charge density of the membrane is given by the
equation presented by Dobrzynska et al. (2006):
d ¼ð aBþ   aA Þ F ð11Þ
where F ¼ 96;487C=mol is the Faraday constant.
Elimination of aAH, aANa, aA , aBOH,aBCl and aBþ
from the above equations yields the following formula
(Dobrzynska et al. 2006):
d
F
¼
CB
1 þ KBOHaOH  þ KBClaCl   
CA
1 þ KAHaHþ þ KANaaNaþ
ð12Þ
Determination of the searching parameters requires a
simpliﬁcation of the above equation to a linear form at high
H
? (aH? ? ?) and low H
? (aH? ? 0) concentrations,
which were presented by Dobrzynska et al. (2006). In the
former case Eq. 12 was rewritten as a decreasing
exponential function of H
? concentration (Eq. 13) and in
the latter case, as an increasing exponential function of H
?
concentration (Eq. 14) (Dobrzynska et al. 2006).
d
F
¼
CBaHþ
aHþð1 þ KBClaCl ÞþKBOHKW
 
CA
KAHaHþ þ KANaaNaþ þ 1
ð13Þ
d
F
¼
CBaHþ
KBOHKW þ aHþð1 þ KBClaCl Þ
 
CA
KANaaNaþ þ 1 þ KAHaHþ
ð14Þ
The numerator of each term in Eq. 13 was divided by the
denominator to yield two terms. These operations resulted
in a linear equation in the aH? and daHþ ðÞ =F coordinate
system, which was correct for high hydrogen ion
concentrations (aH? ? ?) (Dobrzynska et al. 2006).
daHþ
F
¼
CB
1 þ KBClaCl  aHþ  
CBKBOHKW
ð1 þ KBClaCl Þ
2 þ
CA
KAH
 !
ð15Þ
Applying the same procedure to Eq. 14 resulted in a linear
equation in the 1= aHþ ðÞ and d= FaHþ ðÞ coordinate system,
which was correct for low hydrogen ion concentrations
(aH? ? 0) (Dobrzynska et al. 2006):
d
FaHþ
¼ 
CA
1 þ KANaaNaþ
  
1
aHþ
þ
CB
KBOHKW
þ
CAKAH
ð1 þ KANaaNaþÞ
2
 !
ð16Þ
The coefﬁcients describing these linear functions may be
easily obtained using linear regression and subsequently
applied to calculate the parameters. Calculation of CA, CB,
KAH and KBOH is possible owing to knowledge of the
association constants KANa and KBCl obtained for
phosphatidylcholine liposome membrane (Dobrzynska
et al. 2007). Deﬁning the value of these parameters permits
calculation of the theoretical cell membrane surface charge
from Eq. 12 for comparison to experimental data.
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Contrast Medium SonoVue
SonoVue (Bracco, Milan, Italy) contains the active sub-
stance SF6 gas. It is available as a kit containing one vial of
gas and powder and one preﬁlled syringe containing the
solvent. SonoVue solution was prepared according to the
manufacturer’s instructions by mixing the solvent with
the powder and gas. The solution contains SF6 gas as
microbubbles.
Blood Cell Preparation
Approval for this study was granted by the Ethics Review
Board of Medical University of Bialystok, and informed
consentwasobtainedfromallpatientsatthetimeofscanning
after the nature of the procedure had been fully explained.
Theexaminationwasbasedon20selectedindividuals(12
women and 8 men; mean age 33.2 years, range 18–49) with
hepatic hemangioma size up to 30 mm (19 ± 7.5 mm),
without any other diseases. The size was limited to 30 mm
because hemangiomas of at least 4 cm in diameter are
deﬁned as giant hemangiomas and in some cases give rise to
symptoms because of Kasabach–Merritt syndrome (tumor
leads to decreased platelet counts) (Tani et al. 2010).
There were two control groups. Both consisted of 20
healthy volunteers. The ﬁrst (14 women and 6 men; mean
age 33.3 years, range 18–50) was used to assess the impact
of only ultrasound on the red blood cells and platelets, and
the second (12 women and 8 men; mean age 33.2 years,
range 18–49) was used to compare blood cells.
Blood in the amount of 2 ml was taken immediately
before and 10 min after administration of SonoVue into
biologically clean glass containers containing anticoagu-
lant (sodium citrate) from a separate puncture antecubital
vein without stasis.
All sonographic examinations were performed by a
senior radiologist using Toshiba Aplio (Toshiba Medical
Systems, Otawara, Japan) equipped with pulse subtraction
harmonic imaging software, with the use of a wide-band,
multifrequency convex array abdominal transducer
(3.5 MHz PVT 375BT). A bolus of 2.4 ml of SonoVue was
administered with a 21-gauge peripheral intravenous can-
nula, followed by a 10-ml saline ﬂush. Dynamic real-time
CEUS was then performed using a low mechanical index
(MI 0.08) to avoid microbubble disruption. After SonoVue
injection, the lesion was scanned continuously for up
to 8 min until the enhancement effect began to subside.
CEUS recognition of hemangiomas was based on
enhancement and washing and washout patterns of the
lesion relative to normal hepatic parenchyma during the
three vascular contrast phases: arterial, portal-venous and
late (Lencioni 2006; Correas et al. 2009). Static image
captures as well as dynamic video clips were stored on
digital video disc.
Preparation of Erythrocytes from Blood
Erythrocytes were isolated from 2 ml of anticoagulated
whole blood by centrifugation at 9009g for 8 min at room
temperature. The supernatant, thrombocyte-rich plasma
was removed and saved for subsequent processing, while
the erythrocytes were washed three times with isotonic
saline (0.9% NaCl) at 3,0009g for 15 min. After the ﬁnal
wash, the erythrocyte pellet was resuspended in isotonic
saline for electrophoretic measurement.
Preparation of Thrombocytes from Plasma
The thrombocyte-rich plasma was centrifuged at 4,0009g
for 8 min. The supernatant plasma was removed and dis-
carded. The thrombocyte pellet was washed three times
with isotonic saline by centrifugation at 3,0009g for
15 min. After the ﬁnal wash, thrombocytes were resus-
pended in isotonic saline for electrophoretic measurement.
All solutions and cleaning procedures were performed
with water puriﬁed using a Milli-Qll system (18.2; Milli-
pore, Billerica, MA).
Microelectrophoretic Mobility Measurements
The electrophoretic mobility of erythrocyte or thrombocyte
cells in suspension was measured using laser Doppler
velocimetry and a Zetasizer Nano ZS (Malvern Instruments,
Malvern,UK)apparatus.Measurementswerecarriedoutasa
function of pH. Cell membranes were suspended in NaCl
solutionandtitratedtothedesiredpHusing(HCl ? NaClor
NaOH ? NaCl). The reported values represent the average
of at least six measurements performed at a given pH.
From electrophoretic mobility measurements the surface
charge density was determined using the following equa-
tion (Alexander and Johnson 1949):
d ¼
g   u
d
ð17Þ
where g is the viscosity of solution, u is electrophoretic
mobility and d is the diffuse layer thickness. The diffuse
layer thickness was determined from the following formula
(Barrow 1996):
d ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
e   e0   R   T
2   F2   I
r
ð18Þ
where R is the gas constant, T is the temperature, F is the
Faraday number, I is the ionic strength of 0.9% NaCl and eo
is the permeability of the electric medium.
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The electrophoretic mobility measurements of the blood
cells containing SonoVue formed the basis for investiga-
tions of ion/membrane association phenomena. Experi-
ments were performed at several pH values using 0.155 M
NaCl as a supporting electrolyte. The electrophoretic
mobility values were converted to surface charge density
using Eq. 17. The theoretical values of the surface charge
density were determined by applying Eq. 12 to the exper-
imental data. The association constants of blood cell sur-
face groups with Na
? and Cl
- [KA1Na = 0.230 (m
3/mol),
KB1Cl = 0.076 (m
3/mol)] have been previously reported
(Dobrzynska et al. 2007). The calculated association con-
stants were substituted into Eq. 12 to produce a theoretical
curve. The surface charge densities of the control and
SonoVue erythrocytes are plotted as a function of pH in
Fig. 2. The points denote the experimental values, and the
continuous lines represent the theoretical values obtained
from Eq. 12. The theoretical and experimental surface
charge density values agree between pH 2 and 9 but
diverge slightly in the high pH range. Deviations from the
theoretical curve may be caused by interactions between
the functional groups of the blood cell components.
If we considered an acid solution, a small decrease in
positive charge was observed in erythrocytes after Sono-
Vue use in comparison to control erythrocytes. In basic
solutions we also observed a small change in the negative
charge in erythrocytes after SonoVue in comparison to
control erythrocytes and a small shift of the isoelectric
point of the membrane to high pH values.
The surface charge densities of the control and SonoVue
thrombocytes are plotted as a function of pH in Fig. 3. The
points denote experimental values, and the continuous lines
represent theoretical values obtained from Eq. 12. The
theoretical and experimental surface charge density values
agree between pH 2 and 9 but diverge slightly in the high
pH range.
If we consider an acid solution, any change in positive
charge is observed in thrombocytes with SonoVue in
comparison to control thrombocytes. In basic solutions we
observed an increase of the negative charge in thrombo-
cytes with SonoVue in comparison to control thrombocytes
and a small shift of the isoelectric point of the membrane to
low pH values.
The isoelectric point and surface charge density values
for human erythrocytes and thrombocytes determined using
electrophoresis are presented in Tables 2 and 3, respec-
tively. Data are expressed as mean ± standard deviation.
These data were analyzed using standard statistical
analysis.
The surface charge density values at low pH values in
erythrocytes with SonoVue decreased compared with
control groups (14%); however, at high pH values they
increased compared with the control group (3%, Table 2).
The isoelectric point of SonoVue erythrocyte membranes
(3.60) compared to controls (3.80) slightly shifted to low
pH values.
The surface charge density values at low pH values as
well as at high pH values in thrombocytes with SonoVue
decreased compared with controls (15%); however, at high
pH values they increased compared to controls (33%),
which is presented in Table 3. The isoelectric point of
SonoVue thrombocyte membranes (4.40) compared with
the control group (4.65) showed a considerable shift to low
pH values.
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Fig. 2 pH dependence of surface charge density of erythrocytes:
ﬁlled circle control; open square SonoVue effect (experimental
values are indicated by points and theoretical values, by the curve)
-0,04
-0,03
-0,02
-0,01
0
0,01
0,02
0,03
02468 10 12
pH
s u r f a c e   c h a r g e   d e n s i t y
,
 
C
 
m
-
2
Fig. 3 pH dependence of surface charge density of thrombocytes:
ﬁlled circle control; open square SonoVue effect (experimental
values are indicated by points and theoretical values, by the curve)
Table 2 Surface charge density and isoelectric point values for
human erythrocytes (control and SonoVue effect)
Groups Isoelectric
point
Surface charge density (10
-2 C/m
2)
Low pH values High pH values
Control 3.80 1.04 ± 0.11 –1.31 ± 0.08
SonoVue effect 3.60 0.89 ± 0.09 –1.35 ± 0.09
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trations and their average association constants with
hydrogen (KAH) and hydroxyl (KBOH) ions of erythrocyte
and thrombocyte surface groups were determined as
described previously by Dobrzynska et al. (2006). These
values are presented in Tables 4 and 5, respectively. Data
are expressed as mean ± standard deviation. These data
were analyzed using standard statistical analysis.
The concentration of acidic (4%) functional groups in
erythrocytes with SonoVue decreased compared to con-
trols, and the basic (5%) groups in erythrocytes also
decreased compared to controls (Table 4). The KAH, the
association constant of the acidic groups of the erythrocyte
membrane, increased (15%) with SonoVue compared to
controls; and the KBOH value was only 10% higher com-
pared with the control group.
The experimental results indicate that SonoVue caused a
small decrease in negative and positive charge numbers at
the erythrocyte surface. This corresponded to a slightly
decreased surface concentration of acidic groups (CA) and
basic groups (CB). Changes in functional group composi-
tion on the membrane surface are due to the appearance of
new functional groups and/or to the disappearance of
existing ones as the result of a reaction of SonoVue with
erythrocyte components. Variations in the number and kind
of functional groups bring about variations in CA and CB
and, in turn, in their association constant values. SonoVue
increases the association constants of negatively charged
(KAH) and positively charged (KBOH) groups.
In thrombocytes with SonoVue we observed an increase
of the acidic group’s concentration, CA (3%), and an
increase of the basic functional concentration, CB (11%),
compared with the control group (Table 5). SonoVue
induces an increase in KAH (6%) and KBOH values (11%) in
the thrombocytes compared with the control groups.
The experimental results indicate that SonoVue causes a
small increase in negative and positive charge numbers at
the thrombocyte surface. This corresponded to a slightly
increased surface concentration of acidic groups (CA) and
basic groups (CB). Changes in functional group composi-
tion on the membrane surface are due to the appearance of
new functional groups and/or to the disappearance of
existing ones as the result of a reaction of SonoVue with
thrombocyte components. Variations in the number and
kind of functional groups bring about variations in CA and
CB and, in turn, in their association constant values.
SonoVue increases the association constants of negatively
charged (KAH) and positively charged (KBOH) groups.
The current results demonstrate that SonoVue causes a
small change in the levels of all membrane components
(phospholipids and integral membrane proteins) in eryth-
rocytes and thrombocytes (Tables 4, 5). In addition, our
results have shown that the electrical properties of eryth-
rocyte and thrombocyte membranes are not affected by
SonoVue. An essential property of the electric double layer
is its electrokinetic potential, the potential difference
between the membrane and its environment and the surface
charge. Changes in cell membrane charge are connected
with changes in membrane composition (Szachowicz-
Petelska et al. 2008; Dobrzynska et al. 2008). An increase
in the amount of speciﬁc phospholipids results in the
appearance of additional functional groups, both posi-
tively and negatively charged, at the membrane surface
(Dobrzynska et al. 2010).
In our results we did not observe any changes in surface
charge density of erythrocytes after addition of SonoVue,
but in thrombocytes we observed changes of surface charge
density at high pH values. The changes of negative surface
charge density of thrombocytes probably are connected
with adsorption of the remaining phospholipids from the
SonoVue contrast agent. In our opinion the problem could
be studied by means of model experiments (e.g., bilayer
lipid membranes) as well as in vitro examination of the
SonoVue effect in blood cells.
Table 3 Surface charge density and isoelectric point values for
human thrombocytes (control and SonoVue effect)
Groups Isoelectric
point
Surface charge density (10
-2 C/m
2)
Low pH values High pH values
Control 4.65 1.63 ± 0.10 –1.09 ± 0.19
SonoVue effect 4.40 1.39 ± 0.13 –1.62 ± 0.32
Table 4 Acidic and basic functional group concentrations and
association constants for erythrocyte functional groups and H
? and
OH
- ions
Groups Parameters
CA (10
-6
mol/m
2)
CB (10
-6
mol/m
2)
KAH (10
2
m
3/mol)
KBOH (10
7
m
3/mol)
Control 7.06 ± 0.42 1.54 ± 0.47 3.39 ± 1.12 3.65 ± 0.84
SonoVue
effect
6.82 ± 0.10 1.46 ± 0.08 3.95 ± 0.73 4.07 ± 0.60
Table 5 Acidic and basic functional group concentrations and
association constants for thrombocyte functional groups and H
? and
OH
- ions
Groups Parameters
CA (10
-6
mol/m
2)
CB (10
-6
mol/m
2)
KAH (10
2
m
3/mol)
KBOH (10
7
m
3/mol)
Control 3.67 ± 0.79 1.17 ± 0.21 2.81 ± 1.70 2.04 ± 0.59
SonoVue
effect
3.98 ± 0.08 1.31 ± 0.07 2.98 ± 0.43 2.29 ± 0.56
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that typical small hemangiomas show peripheral nodular
enhancement in the arterial phase and from portal to late
phase nodules have progressive centripetal enhancement
(Dietrich et al. 2007; von Herbay et al. 2010; Zviniene
et al. 2010). There have been no adverse events or technical
difﬁculties encountered in this patient population, and
many authors have also reported no adverse effects of
SonoVue (Bokor et al. 2001; Piscaglia and Bolondi 2006;
Gaibazzi et al. 2009; Tranquart et al. 2009; Beaton et al.
2010).
The normal blood pH is tightly regulated between 7.35
and 7.45. Virtually all degenerative diseases, including
cancer, heart disease, osteoporosis, arthritis, kidney and
gall stones and tooth decay, are associated with excess
acidity in the body. We observed no large changes of the
surface charge density of blood cells in a wide pH range.
We see no reason for limiting the use of SonoVue contrast
medium in clinical diagnostics.
Conclusions
The interaction between blood cell membranes and solu-
tion ions has been well characterized. The dependence of
the surface charge density of the erythrocytes and throm-
bocytes as a SonoVue effect on pH was described using a
mathematical model derived from experimental electro-
phoretic data. The theoretical estimates of electric charge
enabled the determination of association constants for
the functional groups of erythrocytes or thrombocytes and
electrolyte ions. The agreement of the experimental and
theoretical charge variation curves of the erythrocytes as
well as thrombocytes is good between pH 2 and 9. The
deviation observed at a higher pH may be caused by dis-
regarding interactions between the functional groups of
blood cells.
No adverse events or technical difﬁculties were
encountered in the patient population presented in this
study. In our opinion, SonoVue is a safe contrast medium.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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